Good morning :)
$
₹
Baxter International Inc

Baxter International Inc

BAX

NYSE
Asset Logo

Baxter International Inc

BAX

NYSE
$23.700.65% (-0.15)
$
₹
$23.700.65% (-0.15)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Large Cap

With a market cap of $12.3B the stock is ranked 857

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

1.98
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-1.88
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

36.67
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

-9.27%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.83%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 18 analysts' reports

Buy
6 analysts
Hold
11 analysts
Sell
1 analyst

Analysts expect a +21.16% price upside over the next year

Current Price$23.70
Target Price$28.72

Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Peers

Peers

Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
32.99
32.99
1Y Return
21.15%
21.15%
Buy Reco %
74.07
74.07
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
35.73
35.73
1Y Return
11.23%
11.23%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
42.38
42.38
1Y Return
13.09%
13.09%
Buy Reco %
66.66
66.66
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
22.40
22.40
1Y Return
1.1%
1.1%
Buy Reco %
53.12
53.12
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
28.58
28.58
1Y Return
25.18%
25.18%
Buy Reco %
68.75
68.75

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Baxter International Inc -1.9836.67
Abbott Laboratories32.993.451.87
Danaher Corporation35.732.671.19

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

2.8
-0
2.9
-1.1
2.7
-0
2.9
0.1
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue2.492.692.692.752.622.812.832.972.702.96
Net Income0.03-0.310.14-0.510.120.09-0.04-1.12-0.010.12
Net Profit Margin1.48%-11.65%5.18%-18.59%4.8%3.23%-1.62%-37.92%-0.55%4.25%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. Baxter International Inc (BAX) share price today is $23.70 as of September 16, 2026 at 1:30 AM IST. The stock touched a day high of $23.91 and a day low of $23.18.

  2. Baxter International Inc stock trades on NYSE under the ticker symbol BAX.

  3. Baxter International Inc's market capitalization is $12.3B as of September 16, 2026 at 1:30 AM IST.

  4. Baxter International Inc's price-to-earnings (P/E) ratio is N/A as of September 15, 2026.

  5. Baxter International Inc's price-to-book (P/B) ratio is 1.98 as of September 15, 2026.

  6. Yes, Baxter International Inc pays a dividend, with a current dividend yield of 0.83%.

  7. Yes, You can buy Baxter International Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Baxter International Inc shares in three steps: 1. Search Baxter International Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Baxter International Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Baxter International Inc (BAX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.4218 shares at the current price of $23.70.

Loading...